DPP saves sampa

 …from prosecution over forgery, perjury, has been warned that should the country descend into anarchy, lawlessness, Zambians shall hold him and his appointee responsible

By NATION REPORTER

THE Director of Public Prosecution (DPP) Gilbert Phiri yesterday truncated the prosecution of expelled Matero Member of Parliament on forgery and perjury which are criminal matters on grounds that there are civil proceedings in the High Court.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Working night shifts is associated with sleep disorders in more than half of workers, study suggests

Sleep is critical for daytime and neurocognitive functioning, as well as physical and mental health. When people work shifts—in 2015, 21% of workers in the European Union did—their circadian sleep-wake rhythms are commonly disrupted. Now, researchers in the Netherlands have investigated the relationship between different shift working patterns, sociodemographic factors, and sleep disorders.

COVID-19 pandemic study shows adherence to infection precaution measures among health care personnel varies by job role

A new study published in the American Journal of Infection Control (AJIC), based on a survey of health care professionals conducted during the height of the COVID-19 pandemic, suggests that new efforts may be needed to strengthen infection prevention precautions and protect staff members at the highest risk of exposure to dangerous pathogens.

PFAS exposure linked to decreased bone health in adolescents and young adults

Per- and polyfluoroalkyl substances (PFAS), manufactured chemicals used in products such as food packaging and cosmetics, can lead to reproductive problems, increased cancer risk and other health issues. A growing body of research has also linked the chemicals to lower bone mineral density, which can lead to osteoporosis and other bone diseases. But most of those studies have focused on older, non-Hispanic white participants and only collected data at a single point in time.

Studies suggest novel targeted therapies may benefit patients with metastatic HR+/ HER2- breast cancer

Two studies led by researchers at The University of Texas MD Anderson Cancer Center demonstrated clinical benefit from novel targeted therapies, which may offer new treatment options for patients with metastatic hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. The data will be shared in oral presentations today at the 2023 San Antonio Breast Cancer Symposium (SABCS).

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

In patients affected by myelodysplastic neoplasms, the body does not produce enough functional blood cells. Patients suffer from anemia—a lack of red blood cells and hemoglobin—which can progress to acute leukemia. Imetelstat, a new agent beyond the current standard of care, may help to avoid blood transfusions, which can be a burden for MDS patients, especially over a long period of time.